Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

May 27, 2022

50715_rns_2022-05-27_c00247f8-d61a-4f60-930d-6a0c29953a1e.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

27 May 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description
of relevant
securities
Nature of dealings Purchase /
Sale
Total
number of
shares
involved
Total amount
paid / received
Highest (H)
prices paid
/ received
Lowest (L)
prices paid
/ received
CICC Financial
Trading Limited
26 May
2022
Ordinary
shares
Closing / flattening / unwinding of
proprietary positions arising from
unsolicited client-driven dealings. I
confirm this was done no later than
the close of the morning trading
session on the trading day following
the orginatingclient-driven dealing
Purchase 34,000 $886,298.4000 $26.0676 $26.0676

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Other types
of securities
(e.g. equity
swaps)
Client facilitation trades in ordinary
shares arising from wholly
unsolicited client-driven orders by a
client facilitation desk which
operates independently of the
group's proprietary trading desk. I
confirm the resultant proprietary
positions (if any) will be flattened no
later than the close of the morning
tradingsession the next tradingday
Sale 34,000 $888,408.0600 $26.1296 $26.1296

End

Note:

CICC Financial Trading Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

CICC Financial Trading Limited is ultimately owned by China International Capital Corporation Limited.